PMID- 21030334 OWN - NLM STAT- MEDLINE DCOM- 20110503 LR - 20161125 IS - 1876-861X (Electronic) IS - 1876-861X (Linking) VI - 4 IP - 6 DP - 2010 Nov-Dec TI - Periprocedural safety of 64-detector row coronary computed tomographic angiography: results from the prospective multicenter ACCURACY trial. PG - 375-80 LID - 10.1016/j.jcct.2010.08.003 [doi] AB - BACKGROUND: Coronary computed tomographic angiography (CCTA) requires iodinated contrast and often atrioventricular nodal blocking agents and nitroglycerin for heart rate lowering and coronary vasodilation, respectively. To date, the periprocedural safety of CCTA is unknown. OBJECTIVES: The purpose of this study was to evaluate the periprocedural safety of CCTA. METHODS: We prospectively evaluated 232 patients with symptomatic chest pain without preexisting renal insufficiency at 16 sites who underwent CCTA as part of the Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography (ACCURACY) trial. Patients received iodinated contrast, beta-blockers, and nitroglycerin as part of a predefined CCTA protocol. We assessed the rates of adverse events (AEs) related to these agents. RESULTS: As measured by serum creatinine and creatinine clearance, no significant change was observed in renal function from baseline (1.00 +/- 0.19 mg/dL; modification of diet in renal disease [MDRD]: 76.91 +/- 17.96 mL/min/1.73 m(2)) to 48 hours (1.0 +/- 0.2 mg/dL; P = 1.00; MDRD change: 0.2 +/- 12.4 mL/min/1.73 m(2); P = 0.83) or at 30 days (1.0 +/- 0.2 mg/dL; P = 0.52; MDRD change: -0.9 +/- 16.9 mL/min/1.73 m(2); P = 0.77). Mean systolic blood pressure decreased from baseline (133 +/- 19 mm Hg) at 1 hour (125 +/- 17 mm Hg; P < 0.001) and rebounded at 48 hours (133 +/- 17 mm Hg). Mean heart rate decreased from baseline (65 +/- 10 beats/min) at 1 hour (60 +/- 7 beats/min) but rose at 48 hours (69 +/- 11 beats/min; P < 0.001. All patients were asymptomatic from baseline to follow-up. CONCLUSIONS: The performance of CCTA is safe with low rates of AEs. CI - (c) 2010 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved. FAU - Bell, George W AU - Bell GW AD - Department of Medicine, Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, NY 10128, USA. FAU - Edwardes, Michael AU - Edwardes M FAU - Dunning, Allison M AU - Dunning AM FAU - Glasofer, Sidney AU - Glasofer S FAU - Lin, Fay Y AU - Lin FY FAU - Labounty, Troy M AU - Labounty TM FAU - Delago, Augustin AU - Delago A FAU - Budoff, Matthew J AU - Budoff MJ FAU - Min, James K AU - Min JK LA - eng PT - Clinical Trial PT - Journal Article PT - Multicenter Study DEP - 20100818 PL - United States TA - J Cardiovasc Comput Tomogr JT - Journal of cardiovascular computed tomography JID - 101308347 RN - 0 (Adrenergic beta-Antagonists) RN - 0 (Contrast Media) RN - 0 (Vasodilator Agents) RN - AYI8EX34EU (Creatinine) RN - G59M7S0WS3 (Nitroglycerin) SB - IM MH - Acute Kidney Injury/etiology MH - Adrenergic beta-Antagonists/adverse effects MH - Aged MH - Bradycardia/etiology MH - Contrast Media/*adverse effects MH - Coronary Angiography/*adverse effects MH - Coronary Artery Disease/*diagnostic imaging MH - Creatinine/blood/urine MH - Female MH - Follow-Up Studies MH - Humans MH - Hypotension/etiology MH - Male MH - Middle Aged MH - Nitroglycerin/adverse effects MH - Prospective Studies MH - Tomography, X-Ray Computed/*adverse effects MH - Vasodilator Agents/adverse effects EDAT- 2010/10/30 06:00 MHDA- 2011/05/04 06:00 CRDT- 2010/10/30 06:00 PHST- 2010/03/06 00:00 [received] PHST- 2010/07/28 00:00 [revised] PHST- 2010/08/08 00:00 [accepted] PHST- 2010/10/30 06:00 [entrez] PHST- 2010/10/30 06:00 [pubmed] PHST- 2011/05/04 06:00 [medline] AID - S1934-5925(10)00466-1 [pii] AID - 10.1016/j.jcct.2010.08.003 [doi] PST - ppublish SO - J Cardiovasc Comput Tomogr. 2010 Nov-Dec;4(6):375-80. doi: 10.1016/j.jcct.2010.08.003. Epub 2010 Aug 18.